Nolan Sean P.
SEC Form 4 insider trading activity
Nolan Sean P. has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including VTR, TSHA, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: May 15, 2026.
On the most recent filing, Nolan Sean P. is listed as Chief Executive Officer at Taysha Gene Therapies, Inc. Inside the rolling window, Nolan Sean P. reported no open-market purchases and 2 open-market sales totaling $840K in TSHA. The largest disclosed transaction in the window is a sale of 136,789 TSHA shares on Jan 23, 2026, worth $650K.
Companies traded
Other insiders at VTR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$840K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Nolan Sean P. made?
Nolan Sean P. has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including VTR, TSHA since 2026.
Which companies does Nolan Sean P. trade?
Nolan Sean P. has filed SEC Form 4 disclosures for 2 companies, including VTR, TSHA.
When was Nolan Sean P.'s most recent SEC Form 4 filing?
Nolan Sean P.'s most recent SEC Form 4 filing on Tracefour is dated May 15, 2026.
What is Nolan Sean P.'s total buy and sell value in the current window?
Inside the rolling retention window, Nolan Sean P. bought $0 and sold $840K based on SEC Form 4 filings.
What was Nolan Sean P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 136,789 TSHA shares on 2026-01-23, worth $650K, per SEC Form 4 filings.